Want to see AU:MCP full AI Analyst Report?
Top Page
Mcpherson'S Limited
(Sydney:MCP)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.15
▼(-39.58% Downside)
Action:Reiterated
Date:06/20/26
The score is held back primarily by ongoing profitability and cash-flow weakness (negative margins, negative ROE, and a steep free-cash-flow decline). Technicals are modestly supportive in the short term (above 20/50DMA with RSI ~64) but the longer-term trend remains weak (below 100/200DMA). Valuation is difficult to justify with losses and no dividend yield data.
Positive Factors
Improved gross margin
A much improved gross margin (57.88%) indicates stronger pricing power or better sourcing and input cost management. Sustained elevated gross margins provide a structural cushion to absorb SG&A or promotional spend, improving the odds of returning to operating profitability over time.
Negative Factors
Negative profitability
Persistently negative net profit and EBIT/EBITDA margins indicate the core business is not yet generating operating profits. Over months this limits internal reinvestment, damages retained earnings, and requires sustained margin improvement or structural cost changes to achieve durable shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved gross margin
A much improved gross margin (57.88%) indicates stronger pricing power or better sourcing and input cost management. Sustained elevated gross margins provide a structural cushion to absorb SG&A or promotional spend, improving the odds of returning to operating profitability over time.
Read all positive factors
Mcpherson'S Limited (MCP) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$20.15M
Dividend YieldN/A
Average Volume (3M)451.79K
Price to Earnings (P/E)―
Beta (1Y)0.55
Revenue Growth19.92%
EPS Growth11.14%
CountryAU
Employees876
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-0.13
Shares Outstanding143,949,140
10 Day Avg. Volume1,155,699
30 Day Avg. Volume451,786
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)0.45
Price to Sales (P/S)0.23
P/FCF Ratio20.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mcpherson'S Limited Business Overview & Revenue Model
Company Description
McPherson's Limited is a company dedicated to distributing a wide array of health, beauty, and personal care products across Australia, New Zealand, Asia, and international markets. Their extensive portfolio includes cosmetics, haircare solutions,...
How the Company Makes Money
McPherson's makes money primarily by selling branded consumer products through retail and other distribution channels, generating revenue from wholesale product sales (i.e., selling inventory to retailers/distributors at a margin over its cost of ...
Mcpherson'S Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.24M | 138.99M | 144.63M | 155.23M | 214.00M | 200.50M |
| Gross Profit | 62.31M | 80.45M | 35.09M | 47.77M | 90.80M | 87.48M |
| EBITDA | -3.35M | -6.99M | -4.92M | 3.10M | 7.44M | 5.98M |
| Net Income | -16.42M | -15.04M | -15.99M | -5.06M | 333.00K | -5.37M |
Balance Sheet | ||||||
| Total Assets | 116.49M | 117.21M | 146.90M | 190.06M | 215.76M | 199.59M |
| Cash, Cash Equivalents and Short-Term Investments | 12.74M | 9.48M | 24.77M | 7.03M | 13.14M | 7.35M |
| Total Debt | 7.07M | 7.30M | 19.85M | 25.45M | 29.38M | 20.93M |
| Total Liabilities | 45.97M | 44.23M | 57.26M | 80.61M | 94.95M | 84.96M |
| Stockholders Equity | 70.52M | 72.98M | 89.64M | 109.45M | 120.81M | 114.62M |
Cash Flow | ||||||
| Free Cash Flow | 6.08M | 1.57M | 9.64M | 4.70M | 16.32M | 168.00K |
| Operating Cash Flow | 6.31M | 2.21M | 12.34M | 6.55M | 18.57M | 2.69M |
| Investing Cash Flow | -1.85M | -3.62M | 16.29M | -1.85M | -2.25M | -31.80M |
| Financing Cash Flow | -3.54M | -13.91M | -10.90M | -10.91M | -10.59M | 29.42M |
Mcpherson'S Limited Technical Analysis
Negative
0.24
Price Trends
0.14
Negative
0.14
Negative
0.18
Negative
Market Momentum
<0.01
Positive
44.59
Neutral
5.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.15, above the 50-day MA of 0.14, and above the 200-day MA of 0.18, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 44.59 is Neutral, neither overbought nor oversold. The STOCH value of 5.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.
Mcpherson'S Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
50 Neutral | AU$20.15M | -1.07 | -22.89% | ― | 19.92% | 11.14% | |
45 Neutral | AU$3.92M | -3.65 | -10.69% | ― | -23.30% | 78.42% | |
41 Neutral | AU$20.31M | -5.11 | -108.90% | ― | -7.01% | 26.92% | |
41 Neutral | AU$17.33M | -0.91 | 2542.90% | ― | -47.12% | -18.92% | |
40 Underperform | AU$13.33M | -2.78 | -41.69% | ― | 53.69% | 45.24% | |
39 Underperform | AU$16.92M | -17.69 | -321.20% | ― | 2.96% | -866.67% |
* Consumer Defensive Sector Average
AU:MCP
Mcpherson'S Limited
0.14
-0.17
-55.74%
AU:PTL
Pental Ltd.
0.02
-0.03
-57.41%
AU:ZNO
Zoono Group Limited
0.05
0.01
37.14%
AU:SKN
Skin Elements Limited
―
―
―
AU:NUC
Nuchev Pty Ltd
0.09
-0.08
-46.88%
AU:HCT
Holista Colltech Limited
0.05
-0.05
-54.00%
Mcpherson'S Limited Corporate Events
McPherson’s flags weaker FY26 earnings amid model transition and brand impairments
Jul 13, 2026
McPherson’s Limited expects FY26 revenue from continuing operations to fall to about $115 million to $120 million from $139 million in FY25, with underlying EBITDA declining to between $4 million and $4.5 million and net cash easing to $4.5 ...
McPherson’s Updates Daily On-Market Share Buy-Back
Jun 29, 2026
McPherson’s Limited has provided an updated notification to the ASX on its ongoing on-market share buy-back program for ordinary fully paid shares under the code MCP. The latest filing reports that a total of 4,875,130 shares had been repurc...
McPherson’s Performance Rights Lapse After Unmet Conditions
Jun 26, 2026
McPherson’s Limited has confirmed the lapse of 4,079,867 performance rights identified under the ASX security code MCPAJ, following the non-satisfaction or incapacity of the conditions attached to these rights. The cessation of these conditi...
McPherson’s Expands On-Market Buy-Back with Daily ASX Update
Jun 9, 2026
McPherson’s Limited has continued its on-market share buy-back program, as disclosed in its latest Appendix 3C update to the Australian Securities Exchange. The company reported that it had repurchased a total of 4,655,130 ordinary fully pai...
McPherson’s Continues On-Market Share Buy-Back Program
Jun 8, 2026
McPherson’s Limited has continued its on-market share buy-back program, focusing on ordinary fully paid shares under the ASX code MCP as part of its ongoing capital management strategy. The latest daily notification reports that a cumulative...
McPherson’s Updates Market on Ongoing On-Market Share Buy-Back
Jun 3, 2026
McPherson’s Limited has provided an updated notification to the market regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that a total of 4,555,130 shares had been bought back prio...
McPherson’s Continues On‑Market Share Buy‑Back with Daily Purchases
May 28, 2026
McPherson’s Limited has continued its on-market share buy-back of ordinary fully paid shares, reporting that it has repurchased a cumulative 4,495,130 shares prior to the latest trading day. The company disclosed that a further 60,000 shares...
McPherson’s Updates Market on Progress of On‑Market Share Buy‑Back
May 26, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that a total of 4,435,130 shares had been repurchased prior t...
McPherson’s Continues On‑Market Buy‑Back with Daily ASX Update
May 11, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program, confirming that it repurchased a total of 60,000 ordinary fully paid shares in the most recent trading day. Cumulativ...
McPherson’s Advances On‑Market Share Buy‑Back With Daily Disclosures
May 5, 2026
McPherson’s Limited has continued its on‑market share buy‑back program, targeting its ordinary fully paid shares listed under code MCP on the ASX. The company reported cumulative repurchases of 4,015,130 shares prior to the lates...
McPherson’s Updates Securities Trading Policy as It Builds Core Health and Beauty Brands
Apr 30, 2026
McPherson’s Limited, a Sydney-based ASX-listed supplier of established health and beauty brands such as Manicare, Swisspers, Lady Jayne, Dr. LeWinn’s and Fusion Health, continues to build its presence across pharmacy, grocery, health f...
McPherson’s Updates Daily On-Market Share Buy-Back Totals
Apr 30, 2026
McPherson’s Limited has provided an updated notification to the ASX on its ongoing on-market share buy-back program for ordinary fully paid shares. The company reported that, as of the latest daily update dated 1 May 2026, it had repurchased...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Apr 29, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back of ordinary fully paid shares. The company reported that a total of 3,680,130 shares had been bought back before the previous ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.